Latest filing published 09 Jan 2026 for 파로스아이바이오.
컴퍼니케이: trading record in brief
컴퍼니케이 appears in our data through filings on 파로스아이바이오 shares, published by DART (FSS). Over a trading history stretching from 27 July 2023 to 17 December 2025, the count stands at 7 filings.
Every open-market trade on record is a purchase: 7 purchases, and no sale. No amount is published for 7 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and no sales.
No cluster: in 7 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 9 January 2026, reports an open-market purchase in 파로스아이바이오. Filings reach the DART (FSS) feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 컴퍼니케이
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 199,251 sharesKRXDART:20230814000347Canonical exit: 12 Nov 2023 (T+90)
- 199,251 sharesKRXDART:20230803000182Canonical exit: 1 Nov 2023 (T+90)
- 199,251 sharesKRXDART:20230802000332Canonical exit: 31 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230731000444Canonical exit: 29 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230727000557Canonical exit: 25 Oct 2023 (T+90)
- 199,251 sharesKRXDART:20230727000495Canonical exit: 25 Oct 2023 (T+90)
7 of 7 declarations